Zhuo Chen, Fan Li, Chuan Chen. "TRIUNITE-02: A phase 2, open-label, randomized study of neoadjuvant CAPEOX plus tislelizumab and chidamide versus CAPEOX alone in previously untreated, resectable, locally advanced mismatch repair-proficient/microsatellite stable colon cancer.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.tps261